• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

Medtech stories we missed this week: May 19, 2017

May 19, 2017 By Danielle Kirsh

missed medtech

From FDA clearances to touting study data, here are some medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Research & Development Tagged With: Body Vision Medical, Exactech Inc., Lombard Medical Technologies, medtech, NxThera Inc., Rivanna Medical, VisionSense, XpandOrtho

Powering the next generation of ingestible drug delivery devices

May 17, 2017 By Sarah Faulkner

Traditional implants in the gastrointestinal tract are meant to pass through a patient’s system, delivering a drug in short bursts or recording the health of a patient’s colon. But in recent years, scientists have sought after ultra-long lasting ingestible devices that can deliver drugs for several weeks in a patient’s GI tract. Lyndra, Inc., a start-up […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: Brigham & Women's Hospital, Draper, lyndra, Massachusetts Institute of Technology

Nano-drug hitchhikes on white blood cells directly to tumor site

May 16, 2017 By Sarah Faulkner

Researchers from Washington State University have developed a way to target drug delivery to a tumor by attaching the therapeutic to white blood cells. The discovery, which the team describes as a 1st of its kind, could help doctors provide more targeted cancer treatment. The researchers attached a nanoscale particle to a white blood cell […]

Filed Under: Featured, Nanoparticles, Oncology, Preclinical Trials, Research & Development Tagged With: washingtonstateuniversity

Engineered tissue could eliminate radiation for bone marrow transplants

May 15, 2017 By Danielle Kirsh

engineered bone tissue

University of California San Diego engineers have created artificial bone tissue that could eliminate the need for radiation before bone marrow transplants. Shyni Varghese, a bioengineering professor at UC San Diego Jacobs School of Engineering, led a team to develop a bone-like implant to eliminate the pre-treatment radiation that kills stem cells in a patient’s bone […]

Filed Under: Research & Development, Stem Cells Tagged With: bone marrow, bone marrow disease, medtech, University of California San Diego

AdvaMed unveils new tools to assess medical device value

May 15, 2017 By Chris Newmarker

AdvaMed value initiative

AdvaMed today launched a new value initiative that includes extensive tables of questions to help medical device companies formulate value-based arguments. The value framework also includes tools specifically designed for diagnostic technologies, as well as report on understanding evidence and use cases. “Value” has become an important word in medtech in recent years as government and […]

Filed Under: Business/Financial News, Clinical Trials, Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: AdvaMed, value-based care

Senseonics, TypeZero ink development deal for artificial pancreas

May 12, 2017 By Sarah Faulkner

Senseonics

Senseonics (NYSE:SENS) said yesterday that it inked a non-exclusive R&D license agreement with TypeZero Technologies to develop artificial pancreas and decision support systems for its Eversense continuous glucose monitor. The companies plan to integrate glucose readings from the Eversense system with TypeZero’s inControl artificial pancreas algorithms to regulate insulin delivery through a user’s insulin pump. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Research & Development, Wall Street Beat Tagged With: Senseonics, typezerotechnologies

Med device, drug delivery companies join J&J’s Toronto JLABS incubator

May 11, 2017 By Fink Densford

Johnson & Johnson (NYSE:JNJ) said today it has added 24 companies, including those in the medical device and drug delivery fields, to its JLABS incubator facility in Toronto, Canada. The facilities in Toronto now host over 40 companies, according to Johnson & Johnson, all of which are provided with lab space and offices, modular lab […]

Filed Under: Business/Financial News, Research & Development Tagged With: johnsonandjohnson

Researchers use shock waves, nanoparticles to deliver chemo drugs

May 11, 2017 By Sarah Faulkner

Researchers from the University of Turin demonstrated that combining shock waves with nanoparticles can help deliver chemotherapy to tumors in animal models. The team’s work was published in the journal, Endocrine-Related Cancer. Researchers designed the treatment to use extracorporeal shock waves and nanobubbles to more effectively target the cancer drugs to the tumor site. The team […]

Filed Under: Featured, Nanoparticles, Oncology, Pharmaceuticals, Research & Development Tagged With: University of Turin

Researchers combine modified insulin and red blood cells to regulate blood sugar in diabetic mice

May 9, 2017 By Sarah Faulkner

Modified insulin and red blood cells

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have designed a glucose-responsive “smart” insulin delivery system using modified insulin and red blood cells. In an animal study of mice with Type I diabetes, the system effectively reduced blood sugar levels for 48 hours. The team’s work was published […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Preclinical Trials, Research & Development Tagged With: North Carolina State University, University of North Carolina at Chapel Hill

Medtech stories we missed this week: May 5, 2017

May 5, 2017 By Danielle Kirsh

missedmedtech0502

From Biomerics’s $38.5 million expansion in Salt Lake City to new study results and partnerships, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Biomerics opening new corporate HQ Biomerics announced in a May 1 press release that it is moving its corporate headquarters in Salt Lake City. The […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: Accuray Inc., Biomerics, Glytec, medPhoton, medtech, Mevion Medical Systems, Neural Analytics, RAPS, Refocus

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS